Recent Developments: As of mid-2026, the FDA has proposed to exclude popular GLP-1 substances like Semaglutide, Tirzepatide, and Liraglutide from the list, concluding that there is no clinical need to compound them from bulk ingredients when approved versions are available
Do not use your NovoLog FlexPen if the liquid contains particles or is colored
Mounjaro (Tirzepatide) is a weight loss drug that acts on both GLP-1 and GIP receptors
I have a family
Male rodents are frequently used in the VPA-induced ASD model because male animals often display more consistent behavioral alterations in this model (Kazlauskas et al., 2019
References Lee TH, Jawan B, Chou WY, Lu CN, Wu CL, Kuo HM, Concejero AM, Wang CH